New Strong Sell Stocks for January 30th

By Zacks Equity Research | January 30, 2026, 6:08 AM

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Trinseo PLC TSE is a seller of plastics and latex binders. The Zacks Consensus Estimate for its current year earnings has been revised 12.9% downward over the last 60 days.

Grupo Aeroportuario del Pacífico PAC is an operator and manager of airports. The Zacks Consensus Estimate for its current year earnings has been revised 2.1% downward over the last 60 days.

Autolus Therapeutics plc AUTL is a clinical-stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 2% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Grupo Aeroportuario Del Pacifico, S.A. de C.V. (PAC): Free Stock Analysis Report

Trinseo PLC (TSE): Free Stock Analysis Report

Autolus Therapeutics PLC Sponsored ADR (AUTL): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

AUTL

-4.20%

Autolus Therapeutics plc ADR

PAC

-1.30%

Grupo Aeroportuario Del Pacifico SAB de CV ADR

TSE

-6.25%

Trinseo PLC

Latest News

Jan-30	New Strong Sell Stocks for January 30th TSE -6.25% AUTL PAC Zacks
Jan-22	New Strong Sell Stocks for January 22nd AUTL Zacks
Jan-12	Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026 AUTL GlobeNewswire
Jan-06	Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL (obe-cel) on the Cellares Cell Shuttle Platform AUTL GlobeNewswire
Jan-06	Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL (obe-cel) on the Cellares Cell ShuttleTM Platform AUTL Business Wire
Dec-30	Needham ups Autolus target, names top pick for 2026 AUTL TipRanks
Dec-27	Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now? AUTL Insider Monkey
Dec-19	Immunotherapies Replacing Chemotherapy as Blood Cancer Market to Hit $13B by 2030 AUTL PR Newswire
Dec-15	Trinseo Announces Receipt of Notice of Non-Compliance With NYSE Continued Listing Requirements TSE Business Wire
Dec-08	Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025 AUTL GlobeNewswire
Dec-08	Autolus Therapeutics Presents Initial Clinical Data in Pediatric r/r B-ALL Patients and Other Oncology Data at the American Society of Hematology (ASH) Annual Meeting 2025 AUTL GlobeNewswire
Dec-01	Autolus Therapeutics Appoints Ryan Richardson to Board of Directors AUTL GlobeNewswire
Nov-25	NICE Recommends AUCATZYL (obecabtagene autoleucel) as a Treatment Option for Adult Patients (=26 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)¹ AUTL GlobeNewswire
Nov-24	JPMorgan Upgrades GAP Airports (PAC) to Overweight, Cuts Target to 460 Mexican Pesos PAC Insider Monkey
Nov-24	Is Autolus Therapeutics PLC (AUTL) One of the Fastest-Growing Penny Stocks to Buy Now? AUTL Insider Monkey

New Strong Sell Stocks for January 30th

Mentioned In This Article

Latest News

Upgrade your FINVIZ experience